Ani Pharmaceuticals Inc (ANIP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.39% 137.43	131.65	131.83	116.55	106.79
Operating Expenses	6.25% 117.12	124.93	113.88	104.14	96.89
Benefits Costs and Expenses	14.24% 112.09	130.71	120.32	111.30	104.62
Costs And Expenses	6.25% 117.12	124.93	113.88	104.14	96.89
Depreciation and Amortization	3.34% 14.69	15.19	15.21	14.69	14.70
Operating Income/Loss	201.99% 20.31	6.726	17.95	12.40	9.895
Income/Loss From Continuing Operations Before Tax	2,575% 25.34	0.947	11.51	5.249	2.165
Income Tax Expense/Benefit	3,527% 7.128	-0.208	1.571	-0.996	0.726
Income/Loss From Continuing Operations After Tax	1,476% 18.21	1.155	9.94	6.245	1.439
Net Income/Loss	1,476% 18.21	1.155	9.94	6.245	1.439
Preferred Stock Dividends And Other Adjustments	0.00% 0.406	0.406	0.406	0.407	0.406
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,551% 19.10	0.338	18.88	17.69	16.39
Diluted Average Shares	5,135% 19.42	0.371	19.12	17.86	16.53
Basic Earnings Per Share	4,100% 0.84	0.02	0.46	0.30	0.06
Diluted Earnings Per Share	4,000% 0.82	0.02	0.45	0.29	0.06
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	3,510% 1.805	0.05	0.891	0.589	0.113
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	384.87% 2.211	0.456	1.297	0.996	0.519

ELAN

$11.63

1.61%

LNTH

$89.28

2.89%

ITCI

$83.45

0.82%

RDY

$15.37

1.65%

NBIX

$135.42

0.34%

VTRS

$12.52

3.22%